To ask the Scottish Government, in light of the announcement by NHS England on 7 November 2023, whether anastrozole will be introduced as a preventative breast cancer drug by NHS Scotland. The National Cancer Medicines Advisory Group (NCMAG) will review the use of Anastrozole as a preventative treatment for post-menopausal women at a moderate or high risk of breast cancer, along with several other medicines for the chemoprevention of breast cancer at their Council meeting on 21 March 2024 and will publish their advice on 25 April 2024.